Loading…
This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
View analytic
Friday, May 2 • 6:30pm - 8:30pm
Establishing a Plan for Length of Therapy in Multiple Myeloma

Sign up or log in to save this to your schedule and see who's attending!

This program will discuss how clinical evidence supports the use of VELCADE (bortezomib) in patients with previously untreated and relapsed multiple myeloma. Attendees will learn how to establish a plan for length of therapy with VELCADE, as well as patient management strategies, including subcutaneous administration.

Registration opens at 6:30 pm, with the program to start at 6:45 pm. To register in advance, please email epic@theselvagroup.com.

This is hosted by Millennium: The Takeda Oncology Company. 


Friday May 2, 2014 6:30pm - 8:30pm
Ruth's Chris Steakhouse 2041 S. Harbor Blvd, Anaheim, CA 92802
  • CNE Status No CNE
  • Contact Hours of CNE: N/A